Robotic Prostatectomy in India & UAE
Robotic prostatectomy in India from $6,500. da Vinci Xi system, nerve-sparing technique at Apollo, Fortis & Kokilaben. 95% success. Expert robotic urologists.
Estimated cost: $6,500 – $9,000 · Average stay: 4–6 days
Robotic-assisted laparoscopic radical prostatectomy (RALRP), commonly called robotic prostatectomy, uses the da Vinci Surgical System to remove the prostate gland through five to six small keyhole incisions in the abdomen, guided by a 3D high-definition camera and controlled by a surgeon at a console. The robotic system provides a 10x magnified, three-dimensional view of the operative field and translates the surgeon's hand movements into precise, tremor-free movements of miniaturized surgical instruments inside the patient.
Robotic prostatectomy has become the dominant surgical approach for prostate cancer worldwide, replacing open surgery at most high-volume centers. The key clinical advantage over open surgery is the ability to perform a more precise nerve-sparing dissection — preserving the neurovascular bundles that control erectile function — through magnification and articulation that is simply not achievable through a traditional open incision. Studies at high-volume centers show that robotic prostatectomy is associated with earlier recovery of urinary continence, equivalent cancer control rates, and better short-term erectile function recovery compared to open radical prostatectomy.
India's major hospitals — Apollo Hospitals in New Delhi, Chennai, and Hyderabad; Fortis Memorial Research Institute in Gurgaon; Kokilaben Dhirubhai Ambani Hospital in Mumbai; Medanta – The Medicity; and Max Hospital — all have da Vinci surgical systems and urologists who have completed dedicated robotic surgery training programs. Many of these surgeons have performed 500–1,000+ robotic prostatectomies and attend international robotic urology meetings including the Society of Robotic Surgery (SRS) annual conference.
The cost of robotic prostatectomy in India ($6,500–$9,000 all-in) compares to $30,000–$60,000 in the United States and £18,000–£30,000 in the UK private sector. The da Vinci Xi system — the fourth-generation robotic system with improved dexterity, extended reach, and better imaging — is available at multiple Indian centers.
For detailed information on prostate cancer treatment pathways, including the comparison of robotic surgery with radiation therapy alternatives, please see our Prostate Cancer Treatment page. This page focuses specifically on the robotic prostatectomy procedure itself.
What is Robotic Prostatectomy?
Radical prostatectomy — the surgical removal of the entire prostate gland and seminal vesicles — is the most common treatment for localized prostate cancer in men suitable for surgery. The prostate lies deep in the pelvis, surrounded by the bladder, rectum, urethra, and the delicate neurovascular bundles that supply the penis. This anatomical complexity is precisely where the robotic system provides its greatest advantage: the 3D magnification and wristed instrument movements allow the surgeon to see and work around these critical structures with a precision that is not possible with open surgery.
The prostate is removed and the bladder is reconnected to the urethra (vesicourethral anastomosis) — a meticulous multi-suture anastomosis that, when performed precisely, minimizes the risk of urinary leakage and supports early continence recovery. A Foley catheter is left in place for seven to fourteen days while this anastomosis heals.
The nerve-sparing technique aims to preserve the neurovascular bundles by dissecting along the plane immediately adjacent to the prostate capsule — either intrafascial (preserving the entire fascial sheath containing the nerves) or interfascial (a slightly wider dissection), depending on tumor proximity to the capsule margin. Whether nerve-sparing is possible depends on the location of the tumor and the risk of leaving cancer cells at the margin — the surgeon must balance cancer control against functional preservation.
Who Is a Candidate for Robotic Prostatectomy?
Radical prostatectomy - surgical removal of the entire prostate gland, seminal vesicles, and regional lymph nodes - is one of the primary curative treatments for localised prostate cancer. Robotic-assisted laparoscopic prostatectomy (RALP) is now the dominant surgical approach in high-volume centres.
Surgical candidacy criteria: clinically localised prostate cancer (T1-T2, N0, M0); selected locally advanced cancers (T3a-T3b) as part of multimodal treatment; any Gleason/ISUP grade group providing life expectancy is at least 10 years; PSA any level (very high PSA may indicate systemic disease - requires staging to exclude metastases); and patient preference for surgery over radiotherapy after fully informed discussion of functional outcomes.
Contraindications include: metastatic prostate cancer (surgery is palliative and does not cure M1 disease); life expectancy below 10 years from non-cancer causes; severe cardiovascular disease precluding laparoscopic pneumoperitoneum; and prior extensive pelvic surgery or radiation making dissection prohibitively high-risk.
The Robotic Prostatectomy Procedure
The patient is placed under general anesthesia in a steep Trendelenburg position (head tilted sharply down, feet up) to allow gravity to move the bowel away from the pelvis. Five to six small ports are placed in the abdomen; the da Vinci robot is docked and the surgeon moves to the control console. The procedure takes two to three hours for an experienced robotic surgeon.
The bladder is mobilized off the anterior abdominal wall; the endopelvic fascia is incised; the dorsal vascular complex (Santorini's plexus) is ligated to control bleeding at the apex. The bladder neck is divided, the seminal vesicles and vasa deferentia are freed, and the nerve-sparing dissection proceeds along the posterolateral surface of the prostate. The urethra is divided at the apex and the specimen is placed in a retrieval bag. The vesicourethral anastomosis is constructed with a running absorbable suture. A catheter is placed and the robot is undocked. The specimen bag is extracted through one of the port sites, which is then closed.
Procedure Steps
- Patient positioned supine in 30-degree Trendelenburg under general anesthesia; robotic ports placed: one camera port, two working arm ports, two assistant ports.
- Da Vinci robot docked; surgeon at console with 3D binocular viewer; scrub nurse assists at patient side.
- Peritoneum opened; bladder mobilized; space of Retzius developed anteriorly; endopelvic fascia incised; dorsal vascular complex ligated.
- Bladder neck dissection: anterior and posterior bladder neck divided; ureters identified and protected; seminal vesicles and vasa deferentia mobilized.
- Nerve-sparing dissection (bilateral or unilateral as planned): posterior lateral dissection along prostate surface; neurovascular bundles preserved under 10x magnification.
- Apical dissection: urethra identified and precisely divided; specimen completely freed and placed in endoscopic bag.
- Vesicourethral anastomosis: six-suture or running V-Loc suture anastomosis connecting bladder neck to urethra; tested watertight with catheter balloon.
- Extended lymph node dissection performed if oncologically indicated; robot undocked; specimen extracted; ports closed; patient transferred to recovery.
Types of Robotic Prostatectomy
Bilateral Nerve-Sparing Robotic Prostatectomy
The neurovascular bundles (NVB) - running on either side of the prostate and carrying autonomic nerves responsible for erectile function - are carefully preserved using precise robotic dissection with magnified 3D vision. Indicated for T1c and T2a cancers where the NVB is not oncologically threatened. Best erectile function recovery outcomes.
Cost: $8,000 - $18,000
Unilateral Nerve-Sparing Robotic Prostatectomy
One NVB is sacrificed where the cancer is in close proximity to that side; the contralateral NVB is preserved. Balances oncological safety (margin-negative resection) with functional recovery. Reduces but does not eliminate erectile function recovery compared to bilateral sparing.
Cost: $8,000 - $18,000
Extended Lymph Node Dissection (eLND) with Robotic Prostatectomy
For intermediate- and high-risk cancers, an extended lymphadenectomy - removing pelvic, obturator, hypogastric, and common iliac lymph nodes - is performed simultaneously for accurate nodal staging. Extended LND identifies more positive nodes than limited dissection and may improve survival in node-positive patients.
Cost: $10,000 - $20,000 (with eLND)
Salvage Robotic Prostatectomy (after Radiation Failure)
For men with biochemical recurrence (rising PSA) after primary radiation therapy who have no evidence of systemic metastases. Technically demanding due to radiation-induced tissue fibrosis; significantly higher complication rates than primary prostatectomy. Performed only at high-volume centres with specific salvage prostatectomy experience.
Cost: $12,000 - $25,000
Cost Comparison Worldwide
Country — Range — Savings
--- — --- — ---
United States — $30,000 – $60,000 — Baseline
United Kingdom — $18,000 – $30,000 — ~50% savings vs. USA
Germany — $15,000 – $25,000 — ~60% savings vs. USA
India — $6,500 – $9,000 — Up to 80% savings vs. USA
UAE — $20,000 – $30,000 — ~55% savings vs. USA
Robotic prostatectomy cost in India is dominated by the robot time and single-use instrument cost. An extended lymph node dissection (recommended for intermediate and high-risk prostate cancer to stage the pelvic nodes accurately) adds to both cost and operative time but is essential for complete oncological management and is included in Gaf Healthcare's standard robotic prostatectomy protocol.
Gaf Healthcare provides a fully itemized cost quote based on the planned procedure before any booking is made. There are no hidden theater charges or post-operative surprises at our partner institutions.
Recovery & Follow-up
Recovery from robotic prostatectomy is faster and less painful than open surgery. Most patients experience only mild incisional discomfort from the small laparoscopic port sites; the absence of a large abdominal incision means pain is primarily managed with oral tablets rather than IV analgesia. The urethral catheter causes discomfort and urgency throughout its time in place (seven to fourteen days); this is the most bothersome element of the early recovery for most patients.
After catheter removal, most patients have some degree of urinary leakage (stress incontinence) — particularly with coughing, sneezing, or sudden movement. This is expected and improves with pelvic floor exercises. At three months, most patients at high-volume nerve-sparing centers have achieved social continence (using no more than one pad per day); by twelve months, the majority are completely continent. Erectile function recovery follows a slower timeline.
Most patients are fit to fly within seven to ten days of robotic prostatectomy. Gaf Healthcare's protocol includes catheter removal before the patient's departure from India wherever possible.
Recovery Tips
- Start pelvic floor (Kegel) exercises immediately after catheter removal — squeeze, hold for three seconds, release; 10–15 repetitions three times daily; this is the most important continence recovery exercise.
- Use the prescribed post-operative medications — antibiotics for the catheter period, alpha-blockers to ease catheter discomfort, and anti-inflammatory drugs.
- Walk gently from day two; avoid strenuous exercise for four weeks; return to normal activity including light sport at six weeks.
- PSA testing at six weeks post-surgery is critical — the PSA must be undetectable (below 0.1 ng/mL); a detectable PSA indicates residual prostate tissue or cancer.
- If recommended, start penile rehabilitation (daily tadalafil 5 mg or 10 mg, or a PDE5 inhibitor protocol) within the first weeks — early penile rehabilitation improves long-term erectile function recovery.
- Do not drive while the catheter is in place or for two weeks after catheter removal — avoid abdominal straining from braking.
- Continue PSA testing every three to six months for the first two years; biochemical recurrence (rising PSA after achieving undetectable level) requires prompt investigation.
- Consider a referral to a continence physiotherapist if significant leakage persists at three months — biofeedback and advanced pelvic floor training can provide additional benefit.
Risks & Complications
Robotic prostatectomy risks are lower than open prostatectomy for most parameters — blood loss is significantly reduced (average 150–200 mL versus 500–1,000 mL for open), transfusion rates are very low, and wound complications are rare. Procedure-specific risks include: urinary incontinence (nearly universal immediately after catheter removal, improving to complete continence in most patients within 12 months at high-volume centers); erectile dysfunction (dependent on pre-operative function, nerve-sparing completeness, and patient age — most men with bilateral nerve-sparing and good pre-operative function have meaningful recovery by 24 months); anastomotic stricture (bladder neck narrowing, occurring in approximately 2–5% of cases, managed by urethral dilatation or incision); and positive surgical margins (cancer at the edge of the removed tissue, indicating potential residual disease — requiring consideration of adjuvant radiation therapy).
The most important determinant of functional outcomes is surgeon experience and case volume. Choosing a robotic urologist who has performed more than 500 robotic prostatectomies is strongly associated with better continence and potency outcomes.
Why GAF Healthcare
Robotic prostatectomy requires careful surgeon selection — not all robotic urologists achieve the same functional outcomes, and the difference between low-volume and high-volume operators is clinically significant. Gaf Healthcare partners exclusively with urologists who have performed over 500 robotic prostatectomies and who can provide peer-reviewed publications or outcome data supporting their results.
We facilitate a pre-operative video consultation between the patient and the surgeon so that questions about nerve-sparing, lymph node dissection, continence, and potency outcomes can be asked and answered directly before the patient commits to traveling. We provide written operative notes, surgical pathology reports, and discharge instructions for the patient's urologist and GP at home.
Frequently Asked Questions
Is robotic prostatectomy better than open surgery?
At high-volume robotic centers, robotic prostatectomy is associated with lower blood loss, fewer transfusions, shorter hospital stay, less post-operative pain, and equivalent cancer control compared to open radical prostatectomy. Functional outcomes (continence and potency) are operator-dependent — experienced high-volume robotic surgeons achieve superior functional results to both open and lower-volume robotic programs. The robot is a tool; surgeon skill and volume remain the primary determinants of outcome.
Will I need radiation therapy after robotic prostatectomy?
Most patients with localized prostate cancer who achieve an undetectable PSA after surgery do not require further treatment. Adjuvant radiation therapy is considered when pathological analysis shows positive surgical margins (cancer at the cutting edge), seminal vesicle invasion, or extension beyond the prostate capsule. Salvage radiation therapy is offered when PSA rises after surgery (biochemical recurrence). These decisions are made collaboratively between the urologist and radiation oncologist based on final pathology and PSA response.
How long will I have a catheter after surgery?
Most patients have a urethral catheter for seven to fourteen days after robotic prostatectomy, while the vesicourethral anastomosis heals. Catheter duration may be shorter (five to seven days) in patients with a particularly secure anastomosis, or longer in complex cases. A cystogram (contrast X-ray to confirm anastomotic integrity) is sometimes performed before catheter removal. The catheter is removed at an outpatient appointment; Gaf Healthcare ensures this appointment takes place before the patient departs India where possible.
Is nerve-sparing surgery always possible?
Nerve-sparing is performed when it is oncologically safe to do so — i.e., when the tumor is not adjacent to or invading the neurovascular bundles. Pre-operative MRI (especially multiparametric MRI with T2-weighted, diffusion, and perfusion sequences) helps predict this. Intraoperatively, the surgeon assesses the capsular anatomy and makes the final decision. If there is any concern about cancer invading or abutting the bundle, a wide excision that includes the bundle on that side is performed to ensure negative margins — cancer control takes priority over nerve preservation.
What is the likelihood of requiring additional treatment after prostatectomy?
For low-risk prostate cancer (Gleason 6, PSA below 10, stage T1–T2a), the probability of biochemical recurrence at ten years is approximately 15–20% with well-performed robotic prostatectomy at high-volume centers. Intermediate-risk disease has approximately 25–35% recurrence probability; high-risk disease approximately 40–50%. Recurrence is detected by rising PSA; salvage radiation therapy achieves biochemical control in a significant proportion of patients with early recurrence (PSA below 0.5 at time of radiation).
How soon can I have sex after robotic prostatectomy?
Most surgeons advise waiting until six weeks after surgery before attempting sexual activity. Erectile function recovery after nerve-sparing surgery is a slow process taking 12–24 months in most patients. Early penile rehabilitation — daily low-dose phosphodiesterase inhibitor (tadalafil 5 mg or sildenafil 25–50 mg) beginning as soon as three to four weeks post-operatively — is strongly recommended to maintain penile health and accelerate recovery. A sexual health specialist referral is advisable for patients who have not recovered adequate function by twelve months.